Drugs in R&D

Drugs R D

1174-5886

1179-6901

Therapeutic Area

Clinical Pharmacology, Pharmacology, Pharmacy, Research

Academics, Allergists, Andrologists, Anesthesiologists, Cardiologists, Clinical Pharmacologists, Clinicians, Dermatologists, Endocrinologists, Family Practice Physicians, Gastroenterologists, General Practitioners, Geriatricians, Gynecologists, Internists, Nephrologists, Neurologists, Oncologists, Pain Specialists, Pharmacists, Pharmacologists, Psychiatrists, Researchers, Rheumatologists, Scientists, Urologists

Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy. The Journal includes: - Clinical research on new and established drugs, in all therapeutic areas - Preclinical research of direct relevance to clinical drug development; - Short communications and case study reports that meet the above criteria will also be considered; - Reviews are welcomed - Studies with negative/neutral outcomes or discontinued drugs are also considered Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs in R&D may be accompanied by plain language summaries to assist readers in understanding important medical advances. All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication. Drugs in R&D publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval. The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access. The journal Also offers the ability to create digital features as well as host them.

No associations affiliated with this journal

Adis, part of Springer Nature

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines